葛根素注射液对冠心病患者PCI术后并发症的影响  

Effects of Puerarin injection on postoperative complications of PCI in patients with coronary heart disease

作　　者：王明磊[1] 杨秀慧[1] WANG Minglei;YANG Xiuhui(Luohe Central Hospital, Luohe Henan 462000, China)

机构地区：[1]漯河市中心医院,河南漯河462000

出　　处：《中国民康医学》2018年第24期15-16,共2页Medical Journal of Chinese People’s Health

摘　　要：目的:观察葛根素注射液对冠心病患者经皮冠状动脉介入(PCI)术后并发症的影响。方法:选取84例拟行PCI术的冠心病患者作为研究对象,依据随机数字表法将其分为观察组和对照组各42例,对照组给予常规治疗,观察组在对照组基础上联合葛根素注射液治疗,比较两组心绞痛、心律失常的发生率及不良反应发生情况。结果:观察组心绞痛、心律失常发生率均明显低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:在常规治疗基础上采用葛根素注射液可有效降低冠心病患者PCI术后心绞痛和心律失常发生率,效果优于单纯常规治疗。Objective: To investigate effects of Puerarin injection on postoperative complications of percutaneous coronary intervention(PCI) in patients with coronary heart disease. Methods: 84 patients with coronary heart disease selected for PCI surgery were selected as the research objects. They were divided into observation group(n=42) and control group(n=42) according to the random number table method. The control group was given routine treatment, while the observation group was given the routine treatment + Puerarin injection treatment. The incidence of adverse reactions, such as angina pectoris and arrhythmia, were compared between the two groups. Results: The incidence of angina pectoris and arrhythmia in the observation group were signifi cantly lower than that in the control group, and the difference was statistically signifi cant(P<0.05). There was no signifi cant difference in the incidence of adverse reactions between the two groups(P>0.05). Conclusions: Puerarin injection on the basis of the conventional treatment can effectively reduce the incidence of angina pectoris and arrhythmia after PCI in the patients with coronary heart disease. Moreover, it is superior to the conventional treatment.

关 键 词：经皮冠状动脉介入术 葛根素 冠心病 心绞痛 心律失常 

分 类 号：R541.4[医药卫生—心血管疾病]